| 发明名称 |
TREATMENT OF HEPATITIS C VIRUS INFECTIONS WITH TELAPREVIR (VX-950) IN PATIENTS NON-RESPONSIVE TO TREATMENT WITH PEGYLATED INTERFER0N-ALPHA-2A/2B AND RIBAVIRIN |
| 摘要 |
Disclosed herein is the use of VX-950 or a pharmaceutically acceptable salt thereof in an amount of about 750 mg or in an amount of about 1125 mg for the manufacture of a medicament for co-administration with pegylated interferon and ribavirin to a P/R non-responsive patient infected with Hepatitis C virus.
|
| 申请公布号 |
NZ588655(A) |
申请公布日期 |
2012.12.21 |
| 申请号 |
NZ20090588655 |
申请日期 |
2009.04.23 |
| 申请人 |
VERTEX PHARMACEUTICALS INCORPORATED |
发明人 |
MCNAIR, LINDSAY;MCHUTCHISON, JOHN |
| 分类号 |
A61K31/454;A61K31/13;A61K31/7056;A61K31/7072;A61K38/21;A61P1/16;A61P31/12;A61P31/14 |
主分类号 |
A61K31/454 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
